GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » Gross-Profit-to-Asset %

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Gross-Profit-to-Asset % : 19.58% (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Luoxin Pharmaceuticals Group Stock Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was ¥1,015 Mil. Luoxin Pharmaceuticals Group Stock Co's average Total Assets over the quarter that ended in Jun. 2024 was ¥5,185 Mil. Therefore, Luoxin Pharmaceuticals Group Stock Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 19.58%.


Luoxin Pharmaceuticals Group Stock Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Luoxin Pharmaceuticals Group Stock Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luoxin Pharmaceuticals Group Stock Co Gross-Profit-to-Asset % Chart

Luoxin Pharmaceuticals Group Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.36 42.86 37.60 10.89 16.53

Luoxin Pharmaceuticals Group Stock Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.94 17.11 16.92 19.73 19.58

Competitive Comparison of Luoxin Pharmaceuticals Group Stock Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Luoxin Pharmaceuticals Group Stock Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luoxin Pharmaceuticals Group Stock Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luoxin Pharmaceuticals Group Stock Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Luoxin Pharmaceuticals Group Stock Co's Gross-Profit-to-Asset % falls into.



Luoxin Pharmaceuticals Group Stock Co Gross-Profit-to-Asset % Calculation

Luoxin Pharmaceuticals Group Stock Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1093.95/( (8118.89+5117.407)/ 2 )
=1093.95/6618.1485
=16.53 %

Luoxin Pharmaceuticals Group Stock Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=1015.248/( (5117.183+5253.567)/ 2 )
=1015.248/5185.375
=19.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Luoxin Pharmaceuticals Group Stock Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Luoxin Pharmaceuticals Group Stock Co Business Description

Traded in Other Exchanges
N/A
Address
85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203
Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.
Executives
Ye Bang Mi Supervisors
Fang Xiu Bao Directors, executives
Zhu Fu Lin Directors, executives
Chen Li Supervisors
Yao Liang Directors, executives

Luoxin Pharmaceuticals Group Stock Co Headlines

No Headlines